The biotech sector is entering a golden age of innovation, powered by a new wave of startups pushing boundaries in genomics, cell therapy, and precision medicine. These 20 biotech companies have secured between $10M and $50M in recent funding, giving them the momentum to scale breakthroughs that could redefine healthcare.
From AI-driven drug discovery to next-gen diagnostics and biomanufacturing, these startups are laying the foundation for the future of medicine.
Meet 20 Biotechnology Startups Changing the Game with $10M–$50M
Meet the companies turning scientific ambition into real-world solutions—one breakthrough at a time.
Now, let’s take a look at 20 biotech startups that are making a significant impact with their groundbreaking work and recent funding success.
| Company | Founded | Location | Number of Employees | Last Funding | Last Funding Date | Total Funding |
|---|---|---|---|---|---|---|
| Verismo Therapeutics | 2020 | Philadelphia, PA, USA | 11-50 | $4.05M | Jan 7, 2025 | $44.2M |
| GEMMABio | 2024 | Philadelphia, PA, USA | 51-100 | $34M | Dec 23, 2024 | $34M |
| Portal | 2023 | Watertown, MA, USA | 1-10 | $7M | Dec 19, 2024 | $12M |
| March Biosciences | 2021 | Houston, TX, USA | 1-10 | $28.4M | Oct 23, 2024 | $46.6M |
| Diakonos Oncology | 2022 | Houston, TX, USA | 11-50 | $11.4M | Aug 26, 2024 | $11.4M |
| Rubi Laboratories | 2020 | San Francisco, CA, USA | 11-50 | $969K | Dec 5, 2024 | $19.33M |
| Curve Biosciences | 2021 | Mountain View, CA, USA | 1-10 | $17.69M | May 13, 2024 | $17.69M |
| Tiny Health | 2020 | Walnut Creek, CA, USA | 11-50 | $8.5M | Mar 5, 2024 | $13M |
| Spear Bio | 2021 | Weston, MA, USA | 11-50 | $45M | Jul 29, 2024 | $45M |
| Myrobalan Therapeutics | 2021 | Medford, MA, USA | 11-50 | $9M | Jul 29, 2024 | $33.4M |
| Onc.AI | 2020 | San Carlos, CA, USA | 11-50 | $2M | Oct 24, 2024 | $33M |
| Arkea Bio | 2022 | Charlestown, MA, USA | 11-50 | $26.5M | May 8, 2024 | $38.5M |
| Neuro42 | 2020 | San Francisco, CA, USA | 11-50 | $15.55M | Aug 15, 2024 | $28.35M |
| MiLaboratories | 2021 | Sunnyvale, CA, USA | 11-50 | $10M | Oct 10, 2024 | $12.36M |
| Kanvas Biosciences | 2020 | Monmouth Junction, NJ, USA | 11-50 | $12.5M | Jul 1, 2024 | $28.41M |
| Cradle | 2024 | San Francisco, CA, USA | 11-50 | $48M | Jun 6, 2024 | $48M |
| Auxilius | 2020 | Brooklyn, NY, USA | 11-50 | $10M | Mar 15, 2024 | $20M |
| Linus Biotechnology | 2020 | New Rochelle, NY, USA | 11-50 | $6.15M | Aug 12, 2024 | $31.65M |
| Doron Therapeutics | 2023 | Chapel Hill, NC, USA | 1-10 | $11M | Nov 25, 2024 | $11M |
| LTZ Therapeutics | 2022 | San Francisco, CA, USA | 11-50 | $20M | Jul 30, 2024 | $47M |
1. Verismo Therapeutics
- Founded: 2020
- Location: Philadelphia, Pennsylvania, USA
- Industry: Biotechnology, Health Care, Medical
- Number of Employees: 11-50
- Last Funding Amount: $4.05M (Latest Round: Jan 7, 2025)
- Total Funding Amount: $44.2M
Verismo Therapeutics is a biotechnology company dedicated to advancing therapeutic solutions for various medical conditions. With a focus on cutting-edge medical research, the company develops innovative treatments aimed at improving patient outcomes and enhancing healthcare practices.
Verismo Therapeutics is committed to harnessing the power of biotechnology to bring new treatments to market, working to address unmet medical needs in the healthcare sector. Through its ongoing research and development efforts, the company aims to create impactful therapies that change lives.
2. GEMMABio
- Founded: 2024
- Location: Philadelphia, Pennsylvania, USA
- Industry: Biotechnology, Health Care, Therapeutics
- Number of Employees: 51-100
- Last Funding Amount: $34M (Latest Round: Dec 23, 2024)
- Total Funding Amount: $34M
GEMMABio is a biotechnology company focused on developing innovative therapeutics aimed at improving human health. The company specializes in cutting-edge biopharmaceutical solutions, targeting some of the most challenging diseases in the healthcare sector. Through advanced research and collaboration, GEMMABio is committed to delivering groundbreaking therapies to the market that can transform patient care and overall treatment outcomes.
As the company advances its mission to improve lives, GEMMABio is dedicated to ensuring that its solutions address critical medical needs and offer promising alternatives for better health management.
3. Portal
- Founded: 2023
- Location: Watertown, Massachusetts, USA
- Industry: Biotechnology
- Number of Employees: 1-10
- Last Funding Amount: $7M (Latest Round: Dec 19, 2024)
- Total Funding Amount: $12M
Portal is a biotechnology company dedicated to pioneering new solutions within the biotech industry. The company focuses on developing advanced platforms and technologies that aim to address critical challenges in human health. By leveraging cutting-edge research and innovation, Portal is working toward transformative breakthroughs that can have a significant impact on therapeutic and healthcare advancements.
With a team of experts in the field, Portal is committed to advancing the scientific landscape, ensuring that its solutions offer tangible benefits to medical professionals and patients alike.
4. March Biosciences
- Founded: 2021
- Location: Houston, Texas, USA
- Industry: Biotechnology, Health Care, Life Science
- Number of Employees: 1-10
- Last Funding Amount: $28.4M (Latest Round: Oct 23, 2024)
- Total Funding Amount: $46.6M
March Biosciences is a cutting-edge biotechnology company based in Houston, Texas. Specializing in life sciences and health care, the company is focused on advancing scientific research and innovations that can significantly impact human health. By utilizing advanced biotechnology platforms, March Biosciences aims to deliver transformative solutions that address the challenges faced in life science research and medical treatments.
The company’s focus on innovation and groundbreaking technologies makes it a prominent player in the biotechnology industry, with a commitment to developing next-generation solutions that can improve patient care and health outcomes.
5. Diakonos Oncology
- Founded: 2022
- Location: Houston, Texas, USA
- Industry: Biotechnology, Oncology, Pharmaceutical
- Number of Employees: 11-50
- Last Funding Amount: $11.4M (Latest Round: Aug 26, 2024)
- Total Funding Amount: $11.4M
Diakonos Oncology, located in Houston, Texas, is an emerging biotechnology company specializing in oncology and pharmaceutical advancements. With a focus on developing innovative treatments for cancer, the company is leveraging cutting-edge research and technologies to create targeted therapies that can improve patient outcomes and quality of life.
By bringing together a team of experts in biotechnology and oncology, Diakonos Oncology is working to make meaningful contributions to the fight against cancer, aiming to revolutionize how cancer is treated with its breakthrough solutions.
6. Rubi Laboratories
- Founded: 2020
- Location: San Francisco, California, USA
- Industry: Biotechnology, CleanTech, Manufacturing
- Number of Employees: 11-50
- Last Funding Amount: $969K (Latest Round: Dec 5, 2024)
- Total Funding Amount: $19.33M
Rubi Laboratories, based in San Francisco, California, is a biotechnology company focused on innovative clean technology solutions within the manufacturing sector. By combining cutting-edge biotechnology with sustainable practices, Rubi Laboratories is working to revolutionize the way clean technologies are integrated into industrial processes.
The company is dedicated to making the manufacturing process more environmentally friendly while advancing green technologies that contribute to a cleaner, more sustainable future.
7. Curve Biosciences
- Founded: 2021
- Location: Mountain View, California, USA
- Industry: Biotechnology, Health Care
- Number of Employees: 1-10
- Last Funding Amount: $17.69M (Latest Round: May 13, 2024)
- Total Funding Amount: $17.69M
Curve Biosciences, based in Mountain View, California, is a biotechnology company focused on advancing health care through innovative therapies. The company is developing cutting-edge biotechnology solutions aimed at revolutionizing the healthcare sector, particularly in the realm of personalized treatments.
Curve Biosciences aims to harness the power of biotechnology to create novel therapies that improve patient outcomes, bringing breakthroughs to areas with significant unmet medical needs.
8. Tiny Health
- Founded: May 2020
- Location: Walnut Creek, California, USA
- Industry: Biotechnology, Health Care
- Number of Employees: 11-50
- Last Funding Amount: $8.5M (Latest Round: Mar 5, 2024)
- Total Funding Amount: $13M
Tiny Health, based in Walnut Creek, California, is a biotechnology company dedicated to improving health care through innovative microbiome-based solutions. Specializing in personalized health, Tiny Health provides unique services and products designed to improve wellness, particularly through insights into the gut microbiome.
The company focuses on creating personalized health strategies to optimize wellness and prevent chronic conditions. By leveraging cutting-edge technology and scientific research, Tiny Health offers data-driven approaches to enhance the overall health of its clients. Their products help individuals better understand their microbiomes, empowering them to make informed decisions about their lifestyles, diets, and wellness practices.
9. Spear Bio
- Founded: 2021
- Location: Weston, Massachusetts, USA
- Industry: Biotechnology, Health Care, Health Diagnostics
- Number of Employees: 11-50
- Last Funding Amount: $45M (Latest Round: Jul 29, 2024)
- Total Funding Amount: $45M
Spear Bio is a cutting-edge biotechnology company focused on advancing health diagnostics through innovative molecular detection technologies. With a mission to enhance early disease detection and monitoring, Spear Bio is developing next-generation diagnostic tools that improve accuracy, efficiency, and accessibility for healthcare providers and patients.
By integrating state-of-the-art biosensing techniques and leveraging advanced biomarker analysis, Spear Bio aims to revolutionize diagnostic testing across multiple medical fields, including oncology, infectious diseases, and personalized medicine. Their solutions are designed to provide rapid and reliable results, enabling early intervention and better patient outcomes.
10. Myrobalan Therapeutics
- Founded: 2021
- Location: Medford, Massachusetts, USA
- Industry: Biotechnology, Health Care
- Number of Employees: 11-50
- Last Funding Amount: $9M (Latest Round: Jul 29, 2024)
- Total Funding Amount: $33.4M
Myrobalan Therapeutics is a pioneering biotech company focused on developing breakthrough treatments for complex diseases. With a strong emphasis on innovative drug discovery and therapeutic development, Myrobalan is dedicated to addressing unmet medical needs in areas such as oncology, neurology, and metabolic disorders.
The company leverages cutting-edge scientific research and advanced biotechnological approaches to create novel therapeutics that improve patient outcomes. By harnessing the power of precision medicine and targeted drug delivery, Myrobalan aims to bring safer and more effective treatments to the healthcare industry.
11. Onc.AI
- Founded: 2020
- Location: San Carlos, California, USA
- Industry: Biotechnology, Health Diagnostics
- Number of Employees: 11-50
- Last Funding Amount: $2M (Latest Round: Oct 24, 2024)
- Total Funding Amount: $33M
Onc.AI is a cutting-edge biotech company leveraging artificial intelligence to revolutionize cancer diagnostics and treatment planning. By combining AI-powered imaging analysis with molecular and clinical data, Onc.AI aims to provide more accurate and personalized insights for oncologists.
The company’s proprietary technology enables early detection, real-time monitoring, and predictive analytics for cancer progression, empowering healthcare professionals to make data-driven decisions. With a mission to enhance patient outcomes and streamline oncology workflows, Onc.AI is at the forefront of AI-driven precision medicine.
12. Arkea Bio
- Founded: 2022
- Location: Charlestown, Massachusetts, USA
- Industry: Biotechnology
- Number of Employees: 11-50
- Last Funding Amount: $26.5M (Latest Round: May 8, 2024)
- Total Funding Amount: $38.5M
Arkea Bio is a pioneering biotechnology company focused on tackling global climate challenges through cutting-edge biological solutions. The company specializes in developing innovative approaches to reduce methane emissions, particularly in agriculture and livestock industries, with the goal of promoting sustainable practices.
By leveraging advanced microbiology and synthetic biology, Arkea Bio is working to create scalable, science-driven solutions that help combat climate change. Their research and development efforts are aimed at producing groundbreaking technologies that significantly reduce greenhouse gas emissions, making industries more environmentally friendly.
13. Neuro42
- Founded: 2020
- Location: San Francisco, California, USA
- Industry: Biotechnology, Medical Device
- Number of Employees: 11-50
- Last Funding Amount: $15.55M (Latest Round: Aug 15, 2024)
- Total Funding Amount: $28.35M
Neuro42 is a cutting-edge biotechnology company revolutionizing the field of brain imaging and diagnostics. Specializing in portable and real-time MRI technology, Neuro42 aims to make advanced neurological imaging more accessible, cost-effective, and efficient. Their innovative devices enable real-time brain imaging, allowing for quicker and more accurate diagnosis of neurological disorders such as strokes, traumatic brain injuries, and tumors.
By integrating artificial intelligence (AI) and machine learning, Neuro42 enhances image processing and diagnostic accuracy, paving the way for smarter and more personalized healthcare solutions. Their compact and portable imaging systems are designed to be deployed in emergency settings, operating rooms, and outpatient clinics, reducing the dependency on traditional, bulky MRI machines.
14. MiLaboratories
- Founded: 2021
- Location: Sunnyvale, California, USA
- Industry: Biotechnology, Genetics
- Number of Employees: 11-50
- Last Funding Amount: $10M (Latest Round: Oct 10, 2024)
- Total Funding Amount: $12.36M
MiLaboratories is a pioneering biotechnology company specializing in immune repertoire sequencing and analysis. The company develops advanced bioinformatics tools and cloud-based solutions for analyzing T-cell and B-cell receptor sequences, enabling researchers and healthcare professionals to better understand immune system responses.
Their proprietary MiXCR platform is widely used in immunology, oncology, and infectious disease research, providing high-precision data processing for immune repertoire profiling. By leveraging machine learning and AI-driven analytics, MiLaboratories enhances biomarker discovery, immunotherapy development, and personalized medicine approaches.
15. Kanvas Biosciences
- Founded: December 2020
- Location: Monmouth Junction, New Jersey, USA
- Industry: Biotechnology, Life Science
- Number of Employees: 11-50
- Last Funding Amount: $12.5M (Latest Round: July 1, 2024)
- Total Funding Amount: $28.41M
Kanvas Biosciences is a pioneering biotechnology company specializing in microbiome research and precision medicine. The company focuses on developing advanced technologies for high-resolution spatial analysis of microbial ecosystems. Their proprietary platform integrates imaging, machine learning, and molecular biology to map microbiomes with unprecedented detail, enabling breakthroughs in diagnostics, therapeutics, and personalized medicine.
Kanvas collaborates with leading academic institutions and pharmaceutical companies to advance microbiome-based drug development, with applications in oncology, infectious diseases, and immune system health. By pushing the boundaries of microbiome science, Kanvas aims to transform precision healthcare, offering targeted treatment strategies that enhance patient outcomes and revolutionize disease prevention.
16. Cradle
- Founded: 2024
- Location: San Francisco, California, USA
- Industry: Biotechnology, Life Science
- Number of Employees: 11-50
- Last Funding Amount: $48M (Latest Round: June 6, 2024)
- Total Funding Amount: $48M
Cradle is an innovative biotechnology company focused on revolutionizing life sciences through cutting-edge artificial intelligence and synthetic biology. With a mission to accelerate drug discovery and biomanufacturing, Cradle develops AI-powered platforms that optimize protein design, enzyme engineering, and cellular therapeutics.
By leveraging machine learning and computational biology, Cradle enables researchers and pharmaceutical companies to create more efficient, sustainable, and scalable biotechnologies. The company collaborates with industry leaders and academic institutions to drive advancements in healthcare, agriculture, and industrial biotech. With a strong commitment to innovation, Cradle is shaping the future of synthetic biology by enhancing precision, efficiency, and scalability in the biotech ecosystem.
17. Auxilius
- Founded: April 1, 2020
- Location: Brooklyn, New York, USA
- Industry: Biotechnology, Information Technology
- Number of Employees: 11-50
- Last Funding Amount: $10M (Latest Round: March 15, 2024)
- Total Funding Amount: $20M
Auxilius is an emerging biotechnology company that bridges the gap between life sciences and information technology. With a mission to enhance healthcare innovation, Auxilius leverages advanced data analytics, artificial intelligence, and machine learning to provide solutions for drug discovery, healthcare automation, and clinical research.
Their platform empowers healthcare professionals, researchers, and pharmaceutical companies to unlock valuable insights from complex biological and medical data. By transforming traditional healthcare practices into data-driven solutions, Auxilius aims to increase efficiency, optimize patient care, and accelerate medical advancements. The company is committed to revolutionizing the life sciences industry by making cutting-edge technologies more accessible and impactful.
18. Linus Biotechnology
- Founded: 2020
- Location: New Rochelle, New York, USA
- Industry: Biotechnology, Health Care
- Number of Employees: 11-50
- Last Funding Amount: $6.15M (Latest Round: August 12, 2024)
- Total Funding Amount: $31.65M
Linus Biotechnology is a leading company in the biotechnology and healthcare sectors, specializing in the development of innovative solutions to address complex medical challenges. Focused on transforming the health landscape, Linus utilizes advanced biotechnology platforms to enable the development of life-saving treatments, diagnostic tools, and health optimization solutions.
Their technology aims to improve patient outcomes by integrating cutting-edge research in genomics and molecular biology. By providing healthcare professionals and researchers with state-of-the-art tools, Linus strives to accelerate drug discovery, personalized medicine, and overall healthcare innovation. Their commitment to improving lives through science is at the heart of every project they undertake.
19. Doron Therapeutics
- Founded: 2023
- Location: Chapel Hill, North Carolina, USA
- Industry: Biotechnology
- Number of Employees: 1-10
- Last Funding Amount: $11M (Latest Round: November 25, 2024)
- Total Funding Amount: $11M
Doron Therapeutics is a dynamic biotechnology company focused on advancing innovative therapeutic solutions for complex diseases. With an emphasis on developing groundbreaking treatments, Doron aims to revolutionize healthcare by leveraging the latest in biotechnology to address unmet medical needs. Their team is dedicated to the research and development of novel therapies that target specific disease mechanisms with high precision.
Driven by a passion for improving patient outcomes, Doron Therapeutics is on the cutting edge of medical advancements, bringing forward solutions that could shape the future of healthcare. Their commitment to excellence in scientific research is at the core of their mission to deliver transformative therapies.
20. LTZ Therapeutics
- Founded: 2022
- Location: San Francisco, California, USA
- Industry: Biotechnology, Health Care
- Number of Employees: 11-50
- Last Funding Amount: $20M (Latest Round: July 30, 2024)
- Total Funding Amount: $47M
LTZ Therapeutics is a cutting-edge biotechnology company dedicated to advancing novel therapeutic solutions in the healthcare industry. With a focus on developing treatments for complex medical conditions, LTZ is at the forefront of creating innovative therapies aimed at improving patient outcomes. The company’s team is committed to translating scientific discoveries into real-world applications that address critical health challenges.
With a robust pipeline of therapies and a passion for groundbreaking research, LTZ Therapeutics is shaping the future of healthcare. Their research-driven approach is poised to revolutionize the way we understand and treat various diseases, making a lasting impact on global health.
Conclusion
Biotech innovation is thriving, and these 20 startups securing $10M–$50M in recent funding are leading the charge. From gene editing and diagnostics to personalized medicine and biomanufacturing, they’re addressing global health challenges with cutting-edge science and bold new approaches. Their progress signals a powerful shift toward smarter, faster, and more targeted healthcare solutions that could reshape medicine for generations to come.
FAQs
Q. How are these biotech Startups transforming the healthcare industry?
Answer: By developing precision medicine, advancing drug discovery, and improving healthcare solutions, these startups are revolutionizing treatment options, providing more effective therapies, and offering new ways to address health challenges.
Q. How do investors see the potential of these biotech startups?
Answer: Investors have shown confidence in these startups by providing substantial funding, signaling a strong belief in their innovative capabilities and the potential to transform industries like healthcare, agriculture, and biotechnology.
Q. How do these startups contribute to advancements in gene editing and genomics?
Answer: Many of the highlighted startups are focusing on developing new methods in gene editing and genomics, which have the potential to revolutionize treatments for genetic diseases, personalized healthcare, and improved patient outcomes.